Lexeo Therapeutics (LXEO) Interest Coverage Ratio Growth (3y) (2025 - 2026)

Lexeo Therapeutics (LXEO) Interest Coverage Ratio Growth (3y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover Growth (3y) (Qtr)
1 Oculis Holding AG 65,734.26 Bn 65,733.97 Bn - -42.41%
2 Nanobiotix 1,919.96 Bn 1,919.90 Bn - -
3 Akari Therapeutics 959.56 Bn 959.56 Bn - -
4 BeOne Medicines 470.76 Bn 465.97 Bn 1.35 Bn 28.11%
5 Vertex Pharmaceuticals 122.29 Bn 115.04 Bn 2.59 Bn -6.89%
6 Regeneron Pharmaceuticals 69.97 Bn 61.22 Bn 3.31 Bn 79.27%
7 Belite Bio 62.06 Bn 62.06 Bn - -
8 Argenx Se 55.72 Bn 50.53 Bn 1.41 Bn -
9 Alnylam Pharmaceuticals 37.50 Bn 34.49 Bn 959.66 Mn 40.09%
10 Lexeo Therapeutics 374.26 Mn 374.26 Mn - 38.74%

Historic Data

Download Data
DateValue
Mar 31, 2026 38.74%
Dec 31, 2025 51.76%
Sep 30, 2025 66.26%